Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

New App for Medical Research, Studies Revealed

Apple Inc. plans to release a new medical research app and announced a series of studies for its use in women’s health, hearing, and heart health. . . . → Read More: New App for Medical Research, Studies Revealed

Gene-Editing Biotech Gains $34M in Early Funds

Sickle cell illustration

A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds

Experimental Drug Shown to Prevent Memory Loss

Neurons illustration

A drug candidate designed to compensate for damage to brain cells from toxic proteins prevented nerve cell damage and memory loss in lab mice. . . . → Read More: Experimental Drug Shown to Prevent Memory Loss

Response by Patients Shown to Precision Lung Cancer Drug

Lung cancer illustration

Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition. . . . → Read More: Response by Patients Shown to Precision Lung Cancer Drug

Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Laptops on a table

Japanese pharmaceutical company Sumitomo Dainippon agreed to acquire five biotechnology companies and gain an equity stake in the Roivant Sciences group. . . . → Read More: Sumitomo Dainippon, Biotechs in $3B Acquisition Deal

Spin-Off Licensing Athletic Microbiome Technology

Runners

A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology

Peanut Desensitizing Found Safe, Effective Long-Term

Bag of peanuts

A clinical trial shows children with peanut allergies taking peanut protein under the tongue avoid allergic reactions from peanuts for up to five years. . . . → Read More: Peanut Desensitizing Found Safe, Effective Long-Term

Gates Investing in HIV, Tuberculosis Immunotherapies

T-cell infected by HIV

The Bill and Melinda Gates Foundation is taking an equity stake in a biotechnology company developing immunotherapies from messenger RNA. . . . → Read More: Gates Investing in HIV, Tuberculosis Immunotherapies

Urine Test Shows Promise for Cancer Screening

Mouse urine samples

Biomedical engineers and materials scientists developed a simple urine test that in samples from lab mice show they can screen for colon cancer. . . . → Read More: Urine Test Shows Promise for Cancer Screening

Deep Learning Techniques Speed Drug Discovery

Synthetic biology

Researchers developed and demonstrated techniques with deep learning to discover new small molecule drugs ready for validation and lab animal tests in 21 days. . . . → Read More: Deep Learning Techniques Speed Drug Discovery